Morgan Stanley’s IGM Biosciences IGMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.5K Sell
20,100
-14,404
-42% -$16.1K ﹤0.01% 6618
2025
Q1
$39.7K Sell
34,504
-62,413
-64% -$71.8K ﹤0.01% 6350
2024
Q4
$592K Sell
96,917
-742
-0.8% -$4.53K ﹤0.01% 5351
2024
Q3
$1.62M Sell
97,659
-13,852
-12% -$229K ﹤0.01% 4770
2024
Q2
$766K Buy
111,511
+10,416
+10% +$71.6K ﹤0.01% 5113
2024
Q1
$976K Sell
101,095
-88,987
-47% -$859K ﹤0.01% 4966
2023
Q4
$1.58M Buy
190,082
+116,288
+158% +$966K ﹤0.01% 5062
2023
Q3
$616K Sell
73,794
-26,142
-26% -$218K ﹤0.01% 5073
2023
Q2
$922K Buy
99,936
+18,252
+22% +$168K ﹤0.01% 4880
2023
Q1
$1.12M Sell
81,684
-10,053
-11% -$138K ﹤0.01% 4795
2022
Q4
$1.56M Sell
91,737
-8,256
-8% -$140K ﹤0.01% 4611
2022
Q3
$2.27M Sell
99,993
-25,149
-20% -$572K ﹤0.01% 4334
2022
Q2
$2.26M Buy
125,142
+28,552
+30% +$514K ﹤0.01% 4437
2022
Q1
$2.58M Buy
96,590
+45,611
+89% +$1.22M ﹤0.01% 4326
2021
Q4
$1.5M Buy
50,979
+5,561
+12% +$163K ﹤0.01% 4788
2021
Q3
$2.99M Buy
45,418
+352
+0.8% +$23.2K ﹤0.01% 4237
2021
Q2
$3.75M Buy
45,066
+2,345
+5% +$195K ﹤0.01% 4083
2021
Q1
$3.28M Buy
42,721
+10,958
+34% +$841K ﹤0.01% 3846
2020
Q4
$2.8M Buy
31,763
+29,217
+1,148% +$2.58M ﹤0.01% 3859
2020
Q3
$188K Sell
2,546
-5,115
-67% -$378K ﹤0.01% 5150
2020
Q2
$559K Buy
7,661
+3,703
+94% +$270K ﹤0.01% 4542
2020
Q1
$223K Sell
3,958
-3,812
-49% -$215K ﹤0.01% 4817
2019
Q4
$297K Buy
7,770
+7,001
+910% +$268K ﹤0.01% 5226
2019
Q3
$14K Buy
+769
New +$14K ﹤0.01% 6110